Holdings of Biotechnology Fund Rydex Series Funds
· 72 declared positions · as of Mar 31, 2026
Original filing · Net assets 135.1M $ · Ten largest lines: 37.2 % of the equity sleeve
Sector breakdown Health care 29.8 % Unattributed 70.2 % Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown US 88.6 % IE 3.0 % GB 1.6 % NL 1.6 % BM 1.4 % CH 1.1 % DE 1.1 % DK 1.0 % KY 0.5 % Shares computed on the equity sleeve, the only part this site carries.
Country Lines Value Share US 63 118.1M $ 88.64 % IE 2 4M $ 2.97 % GB 1 2.2M $ 1.62 % NL 1 2.2M $ 1.62 % BM 1 1.9M $ 1.42 % CH 1 1.5M $ 1.14 % DE 1 1.4M $ 1.08 % DK 1 1.4M $ 1.03 % KY 1 634.1K $ 0.48 %
Positions Company Shares Value Weight AbbVie Inc 45,923 10M $ 7.39 % Amgen Inc 20,093 7.1M $ 5.23 % Gilead Sciences Inc 48,042 6.7M $ 4.96 % Vertex Pharmaceuticals Inc 12,119 5.4M $ 4.01 % Regeneron Pharmaceuticals, Inc. 6,224 4.8M $ 3.56 % Alnylam Pharmaceuticals Inc 10,632 3.5M $ 2.60 % Insmed Inc 20,277 3.3M $ 2.45 % BEONE MEDICINES LTD 10,395 3.1M $ 2.29 % Natera Inc 14,145 2.8M $ 2.09 % United Therapeutics Corp 4,711 2.8M $ 2.07 % Biogen Inc 14,803 2.7M $ 2.01 % Royalty Pharma PLC 55,739 2.7M $ 1.98 % Illumina Inc 19,053 2.3M $ 1.74 % Revolution Medicines Inc 23,475 2.3M $ 1.69 % Moderna Inc 43,818 2.2M $ 1.65 % AstraZeneca PLC 10,974 2.2M $ 1.60 % Argenx SE 2,961 2.2M $ 1.60 % Incyte Corp 22,317 2.1M $ 1.56 % Viatris Inc 150,073 2M $ 1.50 % Bridgebio Pharma Inc 26,764 2M $ 1.47 % Alkermes PLC 56,068 2M $ 1.47 % Jazz Pharmaceuticals PLC 10,448 2M $ 1.46 % Neurocrine Biosciences Inc 14,527 1.9M $ 1.42 % Guardant Health Inc 20,606 1.9M $ 1.41 % Roivant Sciences Ltd 68,372 1.9M $ 1.40 % Ionis Pharmaceuticals Inc 24,870 1.9M $ 1.38 % Exelixis Inc 40,607 1.7M $ 1.29 % Medpace Holdings Inc 3,540 1.7M $ 1.26 % BioMarin Pharmaceutical Inc 29,738 1.7M $ 1.24 % Apellis Pharmaceuticals Inc 41,107 1.7M $ 1.22 % Arrowhead Pharmaceuticals Inc 26,370 1.7M $ 1.22 % Cytokinetics Inc 24,093 1.6M $ 1.18 % Vaxcyte Inc 26,383 1.5M $ 1.14 % CRISPR Therapeutics AG 32,054 1.5M $ 1.13 % Halozyme Therapeutics Inc 22,712 1.5M $ 1.09 % BioNTech SE 16,159 1.4M $ 1.06 % Axsome Therapeutics Inc 8,171 1.4M $ 1.02 % Ascendis Pharma A/S 5,974 1.4M $ 1.01 % Cogent Biosciences Inc 34,752 1.3M $ 0.99 % Arcellx Inc 11,645 1.3M $ 0.99 % TG Therapeutics Inc 39,225 1.3M $ 0.96 % PTC Therapeutics Inc 18,935 1.3M $ 0.96 % Scholar Rock Holding Corp 25,883 1.3M $ 0.94 % Madrigal Pharmaceuticals Inc 2,329 1.2M $ 0.90 % Mirum Pharmaceuticals Inc 13,080 1.2M $ 0.89 % Protagonist Therapeutics Inc 11,198 1.2M $ 0.87 % Amicus Therapeutics Inc 76,280 1.1M $ 0.82 % Rhythm Pharmaceuticals Inc 12,158 1.1M $ 0.78 % Apogee Therapeutics Inc 12,066 1M $ 0.75 % Kymera Therapeutics Inc 11,658 971K $ 0.72 % Twist Bioscience Corp 20,054 953K $ 0.71 % Viking Therapeutics Inc 29,278 952.7K $ 0.71 % Summit Therapeutics Inc 49,213 933.1K $ 0.69 % Nuvalent Inc 9,053 927.5K $ 0.69 % ACADIA Pharmaceuticals Inc 40,673 905.4K $ 0.67 % Travere Therapeutics Inc 30,251 898.8K $ 0.67 % Sarepta Therapeutics Inc 40,226 875.3K $ 0.65 % Celcuity Inc 7,658 874.1K $ 0.65 % Arcutis Biotherapeutics Inc 36,923 869.9K $ 0.64 % Veracyte Inc 26,685 859.5K $ 0.64 % Liquidia Corp 22,146 835.8K $ 0.62 % Beam Therapeutics Inc 31,896 760.1K $ 0.56 % Ultragenyx Pharmaceutical Inc 34,041 713.2K $ 0.53 % Praxis Precision Medicines Inc 2,092 674K $ 0.50 % GRAIL Inc 12,830 663.1K $ 0.49 % Soleno Therapeutics Inc 19,659 658.2K $ 0.49 % Recursion Pharmaceuticals Inc 208,931 641.4K $ 0.47 % Krystal Biotech Inc 2,474 639.1K $ 0.47 % LEGEND BIOTECH CORP 35,054 634.1K $ 0.47 % Intellia Therapeutics Inc 49,463 634.1K $ 0.47 % ADMA Biologics Inc 65,635 591.4K $ 0.44 % Akero Therapeutics Inc 17,387 1.7 $